Physician profile
Allan M Conway
NPI 1003100025
$21,714.91
in general payments reported to CMS, 2019-2025
23 companies · $2,235 in 2025
The $2,235 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,030 · 2020: $218 · 2021: $572 · 2022: $2,047 · 2023: $1,711 · 2024: $13K · 2025: $2,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,480 · Travel and Lodging: $3,734 · Food and Beverage: $3,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,480.00 |
| Travel and Lodging | $3,734.43 |
| Food and Beverage | $3,633.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $12,321.74 | 2023-2024 | Icast, Vasoview Hemopro 2 |
| W. L. Gore & Associates, INC. | $2,541.17 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Gore Tag Conformable Thoracic Endoprosthesis |
| Cook Medical LLC | $1,880.77 | 2019-2025 | Zilver Ptx, Cook, Zenith |
| Boston Scientific Corporation | $1,714.61 | 2021-2025 | Eluvia, General - Vascular Intervention, Seismiq Lithotrip_pi |
| Medtronic, INC. | $471.05 | 2023-2025 | Endurant Iis, Venaseal, Closurefast |
| Medtronic Vascular, INC. | $426.40 | 2019-2020 | |
| Endologix LLC | $327.61 | 2019-2024 | Endocross Device, Torus Stent Graft System |
| Shockwave Medical, INC | $287.05 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Reflow Medical INC | $284.47 | 2024-2025 | |
| Abbott Laboratories | $268.77 | 2019-2024 | Starclose Se, Esprit |
| Philips North America LLC | $229.57 | 2022-2023 | |
| Penumbra, INC. | $207.56 | 2020-2024 | Indigo System |
| Bolton Medical INC | $197.25 | 2021 | |
| Smith+Nephew, INC. | $127.28 | 2023-2025 | Grafix Pl, Collagenase Santyl |
| Terumo Medical Corporation | $120.95 | 2022-2025 | Azur Cx Detachable, Angio-Seal, Glidesheath Slender |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $83.34 | 2023-2025 | Artegraft Vascular Graft, Restoreflow, Hydro Lemaitre Valvulotome |
| Silk Road Medical, INC. | $77.44 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| E.R. Squibb & Sons, L.L.C. | $33.79 | 2023 | Eliquis |
| Stryker Corporation | $29.25 | 2025 | Artix Mt |
| Janssen Pharmaceuticals, INC | $24.11 | 2024 | Xarelto |
| Surmodics, INC. | $22.79 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Angiodynamics, INC. | $19.20 | 2023 | Auryon Laser System 100-120 Vac |
| Tactile Systems Technology INC | $18.74 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.